Estimated reading time: 9 minutes.
Key facts
- Case: Doe v. GoodRx Holdings, Inc., No. 4:23-cv-00501-AMO, U.S. District Court for the Northern District of California (Oakland), before U.S. District Judge Araceli Martínez-Olguín.
- Settlement: GoodRx Holdings, Inc. and advertising company Criteo Corp. have agreed to pay $32 million into a settlement fund. Both deny they violated any law.
- Status: The court granted preliminary approval on September 8, 2026. It has not yet decided whether to give final approval.
- Who is included: All natural persons in the United States who used any website, app, or service made available by or through GoodRx at any time before April 20, 2024.
- Claim deadline: December 29, 2026. Online claims are due by 11:59 p.m. Eastern Time. Mailed claims must be postmarked by that date.
- Proof: The claim form asks you to attest, under a signed certification, that you lived in the United States and used GoodRx before April 20, 2024. It does not ask for receipts or account records.
- Payment: Each approved claimant gets an equal share of what is left after fees and costs. The amount per person is not yet known.
- Final approval hearing: February 11, 2027.
- Not settling: Meta and Google, which are also defendants, are not part of this deal. The claims against them continue.
In this article
- What the settlement provides
- Who the parties are
- What the lawsuit alleges
- The FTC action that came first
- Why the court rejected two earlier versions
- Who qualifies and how to file
- How much you might receive
- Your other options and deadlines
- What happens next
- Frequently asked questions
What the settlement provides
GoodRx users across the United States can now file claims in a $32 million class action settlement over the alleged sharing of their health-related data with advertising and social media companies. The settlement resolves claims against GoodRx and Criteo only.
Under the court-approved notice, GoodRx and Criteo will pay $32,000,000 into a settlement fund. Several costs come out of that fund before any money reaches users: notice and administration costs, taxes, account costs, attorneys' fees and expenses, service awards for the named plaintiffs, and anything else the court approves. What remains, called the net settlement fund, is split equally among everyone who files a valid, timely claim.
The settlement also lets GoodRx and Criteo walk away from the deal if more class members opt out than an agreed number. That number is not public in the notice. This kind of clause is common in class settlements.
Who the parties are
GoodRx Holdings, Inc. The settlement notice describes GoodRx as a combination telehealth and prescription coupon company that serves millions of people each month. Its services named in the notice include the GoodRx website and app, GoodRx Gold, HeyDoctor, and GoodRx Care.
Criteo Corp. The notice identifies Criteo as one of the third-party advertising and social media companies that allegedly received GoodRx user data.
Meta Platforms and Google. The notice calls Meta and Google the "Remaining Defendants." They are accused of receiving the same kinds of data. They have not settled.
The plaintiffs. The case consolidates five proposed class actions filed in early 2023 in the same court. The court appointed Lowey Dannenberg, P.C. and Bursor & Fisher, P.A. as class counsel. The settlement administrator is A.B. Data, Ltd.
What the lawsuit alleges
The plaintiffs allege that between at least 2017 and 2020, GoodRx disclosed sensitive personal health information to advertising and analytics companies, including Criteo, Meta, and Google. According to the notice, that information could include details about prescription medications and health conditions, along with email addresses and phone numbers.
The alleged sharing happened through standard tracking tools built into GoodRx's website and apps. The notice lists JavaScript pixels, software development kits (SDKs), cookies, and application programming interfaces (APIs). The plaintiffs also allege that the receiving companies used the information for their own purposes.
The complaint asserts a long list of claims: intrusion upon seclusion, unjust enrichment, the California Confidentiality of Medical Information Act, the California Invasion of Privacy Act, the California Consumers Legal Remedies Act, California's Unfair Competition Law, New York's General Business Law, the Illinois Consumer Fraud and Deceptive Business Practices Act, negligence, and negligence per se.
GoodRx and Criteo deny they violated any law and dispute the allegations. The notice says they agreed to settle to avoid the expense and uncertainty of continuing the case. No court has found that either company did anything wrong.
Meta and Google are still defendants
This settlement releases claims against GoodRx and Criteo only. The plaintiffs' claims against Meta and Google remain pending in the same case, so a separate outcome for those companies is still possible.
The FTC action that came first
The private lawsuits followed a federal enforcement action. On February 1, 2023, the Federal Trade Commission announced a case against GoodRx over its sharing of users' health information for advertising. The FTC said GoodRx would pay a $1.5 million civil penalty, and described the case as its first enforcement action under the Health Breach Notification Rule. The FTC's proposed order would also bar GoodRx from sharing users' health information with third parties for advertising.
The first private class action was filed the next day, February 2, 2023. The court consolidated the cases on May 3, 2023. The plaintiffs filed a consolidated complaint on May 26, 2023, and the court appointed interim co-lead counsel on July 7, 2023. The parties mediated on January 10 and March 7, 2024.
Why the court rejected two earlier versions
This settlement took more than two years to reach preliminary approval. Judge Martínez-Olguín denied a first request for preliminary approval on the record on June 13, 2025.
She denied a second request in a written order dated January 16, 2026. That order described a class of roughly 54.8 million people. It faulted the plaintiffs for not analyzing the value of each claim, for not doing confirmatory discovery to test the deal, and for a release the court found too broad. The order also cited an estimate of about $9.73 per person if 6 percent of the class filed claims.
The parties then filed their amended settlement agreement with a renewed motion. The agreement now posted on the settlement website was filed with the court on June 1, 2026. The court granted preliminary approval on September 8, 2026. Preliminary approval means the judge found the deal fair enough to send notice to the class. It is not final approval.
Who qualifies and how to file
You are a settlement class member if you are a natural person in the United States who used any website, app, or service made available by or through GoodRx at any time before April 20, 2024. The notice excludes the defendants and their affiliates, Meta and Google, anyone who opts out, and the judges and court staff assigned to the case.
To get paid, you must file a claim. You can file online at the official site, goodrxprivacysettlement.com, or by mail to GoodRx Data Disclosure Settlement, c/o A.B. Data, Ltd., P.O. Box 173138, Milwaukee, WI 53217.
The claim form asks for your name, mailing address, email address, and phone number. It asks you to choose how to be paid: PayPal, Venmo, Zelle, a virtual prepaid card, or a paper check. You then sign an attestation that you lived in the United States and used a GoodRx website, app, or service before April 20, 2024. Each person may file only one claim, even if they received more than one notice.
After you file online, the site displays a printable confirmation of receipt. If the administrator finds a problem with your claim, it will contact you, and you will have 20 days to fix it.
Deadline: December 29, 2026
Online claims close at 11:59 p.m. Eastern Time on December 29, 2026. Paper claims must be postmarked by that date. If you do nothing, you get no payment and are still bound by the settlement's release.
How much you might receive
No one knows yet. The notice says the payment amount will depend on how many approved claims there are. Every approved claimant receives the same share.
Class counsel plan to ask for attorneys' fees of up to one-third of the fund, up to $125,000 in expenses, and service awards of $2,000 for each named plaintiff. Those requests are due by November 24, 2026, and the court must approve them.
The January 2026 estimate of about $9.73 per person at a 6 percent claims rate gives a sense of scale, but it is not a promise. A higher claims rate would mean smaller checks, and a lower one would mean larger checks. For other open claims, see our list of class action cases you can join.
Your other options and deadlines
Exclude yourself. If you want to keep your right to sue GoodRx or Criteo on your own, you can opt out by mailing a written request to the administrator's post office box, postmarked by December 29, 2026. If you opt out, you get no payment.
Object. If you stay in the class and disagree with the settlement, you can file a written objection with the court by December 29, 2026. You may ask to speak at the final hearing in that objection.
Hire your own lawyer. You may appear through your own attorney at your own expense.
Use the official channels
File only through goodrxprivacysettlement.com or the mailing address above. Questions go to the administrator at 1-877-888-9232 or info@goodrxprivacysettlement.com. The notice asks class members not to contact the court.
What happens next
The court will hold the final approval hearing on February 11, 2027 at 11:00 a.m. The judge will decide whether the settlement is fair, reasonable, and adequate, and will rule on the fee and service award requests.
If the court approves the deal, payments still may not go out right away. The notice warns that appeals can take a year or more, and says status updates will be posted on the settlement website.
The claims against Meta and Google continue in the same case. The settlement does not resolve them.
There is one small inconsistency in the official documents. The notice dates the amended settlement agreement November 19, 2025, while the agreement itself is dated November 17, 2025. The notice also lists the case number with a "3:23" prefix, while current court filings use "4:23." Neither difference affects who qualifies or the deadlines.
Frequently asked questions
Who can file a claim in the GoodRx settlement?
Any natural person in the United States who used a website, app, or service made available by or through GoodRx before April 20, 2024, unless they fall into an excluded group such as the defendants, Meta, Google, or court staff on the case.
Do I need proof that I used GoodRx?
The claim form asks for a signed attestation that you lived in the United States and used GoodRx before April 20, 2024. It does not ask for receipts. The administrator can contact you if it needs more information to validate your claim.
What is the deadline to file?
December 29, 2026. Online claims are due by 11:59 p.m. Eastern Time, and mailed claims must be postmarked by that date.
How much will each person get?
The amount is not known. The net fund will be divided equally among approved claimants, so the payment depends on how many people file valid claims.
Did GoodRx admit wrongdoing?
No. GoodRx and Criteo deny they violated any law and dispute the allegations. They agreed to settle to avoid the cost and uncertainty of further litigation.
Does this settlement cover Meta and Google?
No. Meta and Google are not part of this settlement. The plaintiffs' claims against them remain pending in the same case.